Fusen Pharmaceutical Company Limited

Fusen Pharmaceutical Company Limitedverified

1652.HK

Price:

$0.79

Market Cap:

$530.46M

Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers busine...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2018-07-11

Stock Exchange

HKSE

Ticker

1652.HK

The Enterprise Value as of December 2025 (TTM) for Fusen Pharmaceutical Company Limited (1652.HK) is 819.14M

According to Fusen Pharmaceutical Company Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 819.14M. This represents a change of -12.00% compared to the average of 930.86M of the last 4 quarters.

Fusen Pharmaceutical Company Limited (1652.HK) Historical Enterprise Value (quarterly & annually)

How has 1652.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Fusen Pharmaceutical Company Limited over the last ten years is 1.77B. The current 819.14M Enterprise Value has changed 4.53% with respect to the historical average. Over the past ten years (40 quarters), 1652.HK's Enterprise Value was at its highest in in the December 2019 quarter at 3.31B. The Enterprise Value was at its lowest in in the January 2015 quarter at 0.

Quarterly (TTM)
Annual

Average

1.77B

Median

1.41B

Minimum

918.63M

Maximum

3.31B

Fusen Pharmaceutical Company Limited (1652.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Fusen Pharmaceutical Company Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 193.14%

Maximum Annual Enterprise Value = 3.31B

Minimum Annual Increase = -67.52%

Minimum Annual Enterprise Value = 918.63M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024918.63M-24.08%
20231.21B14.69%
20221.05B12.61%
2021936.83M-67.52%
20202.88B-12.85%
20193.31B193.14%
20181.13B-29.81%
20171.61B-26.06%
20162.17B-11.38%

Fusen Pharmaceutical Company Limited (1652.HK) Average Enterprise Value

How has 1652.HK Enterprise Value performed in the past?

The current Enterprise Value of Fusen Pharmaceutical Company Limited (1652.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.06B

5-year avg

1.40B

10-year avg

1.77B

Fusen Pharmaceutical Company Limited (1652.HK) Enterprise Value vs. Peers

How is 1652.HK’s Enterprise Value compared to its peers?

Fusen Pharmaceutical Company Limited’s Enterprise Value is less than China NT Pharma Group Company Limited (820.37M), greater than Yunkang Group Limited (361.60M), greater than Wai Yuen Tong Medicine Holdings Limited (741.88M), greater than Zhongzhi Pharmaceutical Holdings Limited (469.11M), greater than MOG Holdings Limited (234.95M), greater than Suzhou Basecare Medical Corporation Limited (364.85M), less than Charmacy Pharmaceutical Co., Ltd. (1.15B), greater than Pak Fah Yeow International Limited (418.32M), less than Beijing Biostar Pharms Co Ltd (0), greater than Vincent Medical Holdings Limited (492.38M),

Build a custom stock screener for Fusen Pharmaceutical Company Limited (1652.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fusen Pharmaceutical Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fusen Pharmaceutical Company Limited (1652.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fusen Pharmaceutical Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Fusen Pharmaceutical Company Limited's Enterprise Value?

What is the highest Enterprise Value for Fusen Pharmaceutical Company Limited (1652.HK)?

What is the 3-year average Enterprise Value for Fusen Pharmaceutical Company Limited (1652.HK)?

What is the 5-year average Enterprise Value for Fusen Pharmaceutical Company Limited (1652.HK)?

How does the current Enterprise Value for Fusen Pharmaceutical Company Limited (1652.HK) compare to its historical average?